Summit Therapeutics (SMMT) total liabilities

Total liabilities · fiscal 2025
$92.32M

Summit Therapeutics (SMMT) had total liabilities of $92.32M at the end of fiscal 2025 (December 31, 2025). That is 97.2% higher than the $46.81M of fiscal 2024. Figures as of 19 Nov 2026, 01:01 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$92.32M
Change on fiscal 2024
+97.2%
Growth, 5 years
+32.0% a year
Highest on record
$537.51Mfiscal 2022
Lowest on record
$23.05Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Summit Therapeutics total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 32.0% a year. Across the 6 fiscal years on record (2020–2025), the highest was $537.51M in fiscal 2022 and the lowest $23.05M in fiscal 2020.

History · 6 fiscal years

Total liabilities by fiscal year

Summit Therapeutics total liabilities, year by year

Summit Therapeutics (SMMT) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$92.32M 97.2% up
2024$46.81M 62.6% down
2023$125.26M 76.7% down
2022$537.51M 1,686.4% up
2021$30.09M 30.6% up
2020$23.05M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

More on SMMT

Summit Therapeutics, figure by figure

Summit Therapeutics (SMMT) overview: price, valuation and scorecardAll health care companies by market value

Summit Therapeutics total liabilities: questions and answers

How large are Summit Therapeutics's total liabilities?

Summit Therapeutics (SMMT) had total liabilities of $92.32M at the end of fiscal 2025 (December 31, 2025). That is 97.2% higher than the $46.81M of fiscal 2024.

What is the growth rate of Summit Therapeutics's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 32.0% a year.

What are the highest and lowest total liabilities figures on record for Summit Therapeutics?

Across the 6 fiscal years on record (2020–2025), the highest was $537.51M in fiscal 2022 and the lowest $23.05M in fiscal 2020.

How is Summit Therapeutics's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Summit Therapeutics it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Summit Therapeutics (SMMT) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/SMMT/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.